Screening and Early Detection
635 articles
The Benefit of Being Your Own Advocate
Eric Borden decided to advocate for himself when a lesion was found on his pancreas. It was a good choice because it was pancreatic cancer.
Going Two Rounds Against Pancreatic Cancer
Anthony Del Russo has battled pancreatic cancer twice, first with chemo and a Whipple, and again with a total pancreatectomy and radiation.
A Clinical Trial Saved My Life
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.
Using the Lessons of Recovery in my Pancreatic Cancer Treatment
Robert Hessler used the lessons he learned as a recovering alcoholic to help him through the challenges of a Whipple procedure.
Could There Be a Cure in Vitamin C?
Vitamin C has been found to kill cancer cells that carry the KRAS mutation. This mutation is common in pancreatic and colorectal cancers.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
Clinical Trial of Immunotherapy Plus Sunshine Vitamin May Help in Pancreatic Cancer Fight
Can vitamin D make it easier for chemotherapy drugs to reach the pancreatic cancer tumor? A clinical trial is testing this idea.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Predicting Effective Therapy in Pancreatic Cancer
Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.
Standard of Care Plus
Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
The Promise of Organoids
Dr. Brian Wolpin explains how organoids are being used to develop personalized treatment for pancreatic cancer patients.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.